Green Cross Medical Science Corporation (142280) — Cash Flow Quality Index
Green Cross Medical Science Corporation (142280) has a Cash Flow Quality Index of -1.11x as of March 2026. Operating cash flow of ₩-160.64 Million is below net income of ₩144.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 142280 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Green Cross Medical Science Corporation Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Green Cross Medical Science Corporation across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Green Cross Medical Science Corporation to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Green Cross Medical Science Corporation (2014–2025)
Year-by-year earnings quality comparison for Green Cross Medical Science Corporation. For live market cap and the full company financial profile, see 142280 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | ₩7.20 Billion | ₩3.67 Billion | ▲ +82.1% |
| 2024 | 1.08x | ₩3.66 Billion | ₩3.40 Billion | ▼ -52.3% |
| 2023 | 2.26x | ₩4.24 Billion | ₩1.88 Billion | ▲ +273.3% |
| 2020 | -1.30x | ₩-8.76 Billion | ₩6.72 Billion | ▲ +85.6% |
| 2015 | -9.03x | ₩-5.45 Billion | ₩603.26 Million | ▼ -1412.9% |
| 2014 | -0.60x | ₩-2.22 Billion | ₩3.72 Billion | — |